ロード中...
Head-to-head comparison between FOLFIRINOX and gemcitabine plus nab-paclitaxel in the neoadjuvant chemotherapy of localized pancreatic cancer: a systematic review and meta-analysis
BACKGROUND: The benefits of neoadjuvant chemotherapy (NCT) in pancreatic cancer (PC) have been realized and gradually accepted. FOLFIRINOX and gemcitabine and nab-paclitaxel (GA) are the two most widely used regimens for PC NCT. METHODS: The literature was systematically reviewed by searching MEDLIN...
保存先:
| 出版年: | Gland Surg |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8184396/ https://ncbi.nlm.nih.gov/pubmed/34164301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-21-16 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|